Table 5.
Response to abnormal clinical findings
| NT Top End | NT Central Australia | Far West NSW | WA | North QLD | Total | |
|---|---|---|---|---|---|---|
| No. of health centres | client records | 13 | 136 | 2 | 45 | 6 | 103 | 9 | 193 | 4 | 58 | 34 | 535 |
| Record of abnormal BMI (< 20 or > 30) | 3% (4/136) | 20% (9/45) | 2% (2/103) | 6% (12/193) | 5% (3/58) | 6% (30/535)* |
| Documented plan of management | 0% (0/4) | 44% (4/9) | 0% (0/2) | 0% (0/12) | 0% (0/3) | 13% (4/30)* |
| Record of abnormal BP (≥140/90) prior to 28 weeks | 1% (2/136) | 11% (5/45) | 1% (1/103) | 0% (0/193) | 0% (0/58) | 2% (8/535)* |
| Follow up BP done | 100% (2/2) | 60% (3/5) | 100% (1/1) | n/a | n/a | 75% (6/8) |
| Urine tested for protein | 100% (2/2) | 60% (3/5) | 100% (1/1) | n/a | n/a | 75% (6/8) |
| GP/Obstetric referral | 50% (1/2) | 80% (4/5) | 100% (1/1) | n/a | n/a | 75% (6/8) |
| Examination by GP/Obstetrician | 50% (1/2) | 80% (4/5) | 100% (1/1) | n/a | n/a | 75% (6/8) |
| Anti-hypertensive medication prescribed | 50% (1/2) | 20% (1/5) | 100% (1/1) | n/a | n/a | 38% (3/8) |
| Record of abnormal BP (≥140/90) at or after 28 weeks | 1% (1/136) | 13% (6/45) | 5% (5/103) | 3% (6/193) | 0% (0/58) | 3% (18/535)* |
| Follow up BP done | 100% (1/1) | 100% (6/6) | 60% (3/5) | 50% (3/6) | n/a | 72% (13/18) |
| Urine tested for protein | 100% (1/1) | 100% (6/6) | 60% (3/5) | 50% (3/6) | n/a | 72% (13/18) |
| GP/Obstetric referral | 100% (1/1) | 100% (6/6) | 60% (3/5) | 50% (3/6) | n/a | 72% (13/18) |
| Examination by GP/Obstetrician | 100% (1/1) | 100% (6/6) | 100% (5/5) | 50% (3/6) | n/a | 83% (15/18) |
| Anti-hypertensive medication prescribed | 100% (1/1) | 33% (2/6) | 0% (0/5) | 17% (1/6) | n/a | 22% (4/18) |
| Record of abnormal standard glucose challenge test | 17% (23/136) | 22% (10/45) | 10% (10/103) | 4% (7/193) | 17% (10/58) | 11% (60/535)* |
| GTT undertaken | 87% (20/23) | 90% (9/10) | 80% (8/10) | 43% (3/7) | 60% (6/10) | 77% (46/60) |
| Rhesus negative | 1% (1/136) | 0% (0/45) | 7% (7/103) | 4% (8/193) | 3% (2/58) | 3% (18/535)* |
| Anti-D injection given 26-28 wks | 100% (1/1) | n/a | 43% (3/7) | 63% (5/8) | 0% (0/2) | 50% (9/18) |
| Anti-D injection given 34-36 wks | 100% (1/1) | n/a | 29% (2/7) | 63% (5/8) | 0% (0/2) | 40% (8/18) |
| Baby Rhesus positive | 0% (0/136) | 33% (15/45) | 2% (2/103) | 1% (2/193) | 0% (0/58) | 4% (19/535)* |
| Mother given anti-D postnatal | n/a | 0% (0/15) | 100% (2/2) | 100% (2/2) | n/a | 21% (4/19)* |
| Anaemia (Hb < 100 g/L) | 14% (19/136) | 22% (10/45) | 11% (11/103) | 12% (24/193) | 3% (2/58) | 12% (66/535)* |
| Iron prescribed | 84% (16/19) | 100%(10/10) | 91% (10/11) | 75% (18/24) | 50% (1/2) | 83% (55/66) |
| Follow up FBE or Hb test done | 42% (8/19) | 90% (9/10) | 36% (4/11) | 46% (11/24) | 50% (1/2) | 50% (33/66) |
| Nitrites detected by dip stick | 21% (28/136) | 33% (15/45) | 5% (5/103) | 24% (46/193) | 10% (6/58) | 19% (100/535)* |
| Urine sent for MSU | 96% (27/28) | 100%(15/15) | 100% (5/5) | 93% (43/46) | 100% (6/6) | 96% (96/100) |
| Oral antibiotic prescribed | 93% (26/28) | 60% (9/15) | 80% (4/5) | 37% (17/46) | 83% (5/6) | 61% (61/100)* |
| Record of a normal follow up MSU | 46% (13/28) | 100%(15/15) | 40% (2/5) | 26% (12/46) | 83% (5/6) | 47% (47/100)* |
| Rubella antibodies negative or low titre | 35% (47/136) | 7% (3/45) | 15% (15/103) | 15% (28/193) | 7% (4/58) | 18% (97/535)* |
| Rubella immunisation given postnatally | 36% (17/47) | 67% (2/3) | 13% (2/15) | 32% (9/28) | 0% (0/4) | 31% (30/97) |
BP = blood pressure, BMI = body mass index, FBE = full blood examination, GP = general practitioner, GTT = glucose tolerance test, Hb = haemoglobin, MSU = midstream urine, n/a = not applicable.
* P < 0.05 for comparisons between regions.